Tetrasomy 9p syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3310Q99.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Tetrasomy 9p syndrome (also known as isochromosome 9p syndrome or i(9p) syndrome) is a rare chromosomal disorder characterized by the presence of a supernumerary isochromosome composed of two copies of the short arm (p) of chromosome 9, resulting in four copies of the 9p genetic material instead of the normal two. This condition arises sporadically due to a de novo chromosomal rearrangement and is typically detected prenatally or at birth. The syndrome affects multiple body systems and is associated with a wide range of clinical features. Key findings include intellectual disability, growth retardation, craniofacial dysmorphism (such as a bulbous nose, micrognathia, low-set malformed ears, hypertelorism, and cleft lip/palate), skeletal anomalies (joint contractures, hypoplastic phalanges, and abnormal positioning of fingers and toes), congenital heart defects, and renal malformations. Central nervous system abnormalities, including Dandy-Walker malformation and ventriculomegaly, have also been reported. Many affected individuals exhibit hypotonia in infancy. The severity of clinical manifestations is variable, which may partly be explained by tissue-limited mosaicism, where the extra isochromosome is present in only a proportion of cells. There is no specific cure or targeted therapy for tetrasomy 9p syndrome. Management is supportive and symptomatic, involving a multidisciplinary team that may include cardiologists, nephrologists, orthopedic specialists, speech therapists, and developmental specialists. Surgical intervention may be required for congenital heart defects, cleft palate, or other structural anomalies. Early intervention programs and physical therapy are recommended to optimize developmental outcomes. Prognosis varies considerably depending on the severity of malformations and the degree of mosaicism, with some individuals surviving into adulthood while others may have a significantly shortened lifespan due to severe organ involvement.

Also known as:

Clinical phenotype terms— hover any for plain English:

Median cleft palateHP:0009099Abnormal earlobe morphologyHP:0000363PilomatrixomaHP:0030434
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Tetrasomy 9p syndrome.

View clinical trials →

No actively recruiting trials found for Tetrasomy 9p syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Tetrasomy 9p syndrome community →

No specialists are currently listed for Tetrasomy 9p syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Tetrasomy 9p syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Tetrasomy 9p syndromeForum →

No community posts yet. Be the first to share your experience with Tetrasomy 9p syndrome.

Start the conversation →

Latest news about Tetrasomy 9p syndrome

No recent news articles for Tetrasomy 9p syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Tetrasomy 9p syndrome

What is Tetrasomy 9p syndrome?

Tetrasomy 9p syndrome (also known as isochromosome 9p syndrome or i(9p) syndrome) is a rare chromosomal disorder characterized by the presence of a supernumerary isochromosome composed of two copies of the short arm (p) of chromosome 9, resulting in four copies of the 9p genetic material instead of the normal two. This condition arises sporadically due to a de novo chromosomal rearrangement and is typically detected prenatally or at birth. The syndrome affects multiple body systems and is associated with a wide range of clinical features. Key findings include intellectual disability, growth r

How is Tetrasomy 9p syndrome inherited?

Tetrasomy 9p syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Tetrasomy 9p syndrome typically begin?

Typical onset of Tetrasomy 9p syndrome is neonatal. Age of onset can vary across affected individuals.